Inflammatix Announces Additional $12.1 Million Funding From BARDA for ViraBac EZ Acute Infection Test

BURLINGAME, Calif.--(BUSINESS WIRE)-- #AI--Inflammatix receives a third tranche of $12.1 million from BARDA for development of a novel point of care diagnostic for acute infection.

Click to view original post